Rubio J A, Pulpón L A, Cavero M A, Oteo J F, Maicas C, Silva L, Serrano-Fiz S, Burgos R, Artaza M, Téllez G
Servicio de Cardiología, Clínica Puerta de Hierro, Madrid.
Rev Esp Cardiol. 1994 Nov;47(11):777-9.
We present the case of a young man who developed severe cardiomyopathy eight years after receiving high-dose doxorubicin therapy as treatment for diffuse lymphoblastic lymphoma. He underwent cardiac transplantation and eighteen months later the tumor has not recurred and the patient has no cardiac symptoms.
